|
BTG Plc - Company Profile Snapshot
| Company Profile: |
BTG Plc |
| Ticker: |
BGC |
| Exchanges: |
LON |
| 2009 Sales: |
84,800,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Service Organizations |
| Country: |
UNITED KINGDOM |
| Employees: |
155 |
Business Description
BTG Plc. The Group's principal activity developing and commercialising life science technologies. The Group in-licenses, develops and commercialises pharmaceuticals and has a broad pipeline of development programme targeting neurological and other disorders including varicose veins. It acquires the rights to early-stage pharmaceuticals and other medical technologies from a global network of corporations, universities and research institutions. The drug development programme are in the field of oncology, ageing, neuroscience and drug repositioning. The Group's products are Varisolve, Misopess, Benefix, Campath, Infecton, Juvidex and Symadex.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
